反复给予钆喷酸葡胺后炎症脑内钆滞留增加:结合ICP-MS与微米及纳米同步辐射X射线荧光的小鼠概念验证研究
该小鼠概念验证研究显示,在实验性自身免疫性脑脊髓炎(EAE)模型中反复给予钆喷酸葡胺(Gd-DTPA)后,炎症脑组织钆滞留量高于健康对照(EAE组均值5.3 μg/g vs 健康对照组2.4 μg/g),且纳米级钆热点位于炎症活跃区域。作者认为持续炎症可能促进脑组织钆滞留,建议在推荐使用线性钆对比剂增强MRI时考虑神经炎症这一风险因素。
要点
- EAE小鼠反复给予Gd-DTPA后脑钆含量均值5.3 μg/g,高于健康对照的2.4 μg/g。
- 未增强T1WI仅见轻度高信号,但SR-XRF可显示炎症脑内钆沉积分布。
- 纳米SR-XRF显示钆小热点平均直径约160 nm,位于炎症活跃区域。
核心结论
- 反复给予Gd-DTPA后,持续炎症可能促进钆在脑组织中的滞留,作者认为推荐使用线性钆对比剂增强MRI时应将神经炎症视为风险因素。
研究设计与样本
- 小鼠概念验证研究:雌性SJL/J小鼠诱导EAE(n=6),健康对照(n=4),10天内给予2.5 mmol/kg Gd-DTPA共8次(累积剂量20 mmol/kg),自免疫后第14天EAE达最大临床残疾时开始给药。
关键影像表现/征象
- 末次注射后1天SR-XRF可显示炎症脑内钆沉积分布,而未增强T1加权图像仅见轻度信号高信号。
- 微米SR-XRF在所有检测样本中识别出亚微米级钆热点,组织浓度最高达5893 μg Gd/g。
- 纳米SR-XRF显示钆小热点平均直径约160 nm,位于炎症活跃区域。
诊断标准与关键数值
- ICP-MS检测:末次注射后10天内健康与EAE脑均可检出并定量钆;EAE脑钆均值±SD为5.3±1.8 μg/g(范围4.45-8.03 μg/g),健康对照为2.4±0.6 μg/g(范围1.8-3.2 μg/g)。
- SR-XRF:末次注射后1天可显示炎症脑内钆沉积分布;微米SR-XRF识别亚微米级钆热点最高达5893 μg Gd/g组织;纳米SR-XRF显示钆小热点平均直径约160 nm。
临床应用与阅片要点
- 作者认为,在推荐使用线性钆对比剂增强MRI时应将神经炎症视为风险因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of this study was to determine in vivo if brain inflammation leads to increased gadolinium (Gd) retention in brain tissue after repeated applications of Gd-based contrast agents (GBCAs).
MATERIALS AND METHODS: Experimental autoimmune encephalomyelitis (EAE) was induced in female SJL/J mice (n = 6). Experimental autoimmune encephalomyelitis and healthy control mice (n = 4) received 2.5 mmol/kg Gd-DTPA over 10 days (8 injections, cumulated dose of 20 mmol/kg), starting at day 14 post immunization when EAE mice reached the maximal clinical disability. In a group of mice, T1-weighted 2-dimensional RARE images were acquired before the first GBCA injection and 1 day after the last injection. Mice were killed either 1 day or 10 days after the last Gd application. From each single animal, a brain hemisphere was used for Gd detection using inductively coupled plasma mass spectrometry, whereas the other hemisphere was processed for histology and synchrotron x-ray fluorescence spectroscopy (SR-XRF) analysis.
RESULTS: Gadolinium deposition in inflamed brains was mapped by SR-XRF 1 day after the last Gd-DTPA injections, although only mild signal hyperintensity was found on unenhanced T1-weighted images. In addition, using inductively coupled plasma mass spectrometry, we detected and quantified Gd in both healthy and EAE brains up to 10 days after the last injections. However, EAE mouse brains showed higher levels of Gd (mean ± SD, 5.3 ± 1.8 μg/g; range, 4.45-8.03 μg/g) with respect to healthy controls (mean ± SD, 2.4 ± 0.6 μg/g; range, 1.8-3.2 μg/g). By means of micro-SR-XRF, we identified submicrometric Gd hotspots in all investigated samples containing up to 5893 μg Gd/g tissue. Nano-SR-XRF further indicated that Gd small hotspots had an average size of ~160 nm diameter and were located in areas of high inflammatory activity.
CONCLUSIONS: After repeated administrations of Gd-DTPA, ongoing inflammation may facilitate the retention of Gd in the brain tissue. Thus, neuroinflammation should be considered as a risk factor in the recommendation on use of linear GBCA-enhanced MRI.
引用
- Wang S, Hesse B, Roman M, et al. Increased Retention of Gadolinium in the Inflamed Brain After Repeated Administration of Gadopentetate Dimeglumine: A Proof-of-Concept Study in Mice Combining ICP-MS and Micro- and Nano-SR-XRF. Invest Radiol. 2019. PMID: 31033673. doi:10.1097/RLI.0000000000000571
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。